Histamine and the nasal vasculature: The influence of H1 and H2-histamine receptor antagonism

Clinical Otolaryngology and Allied Sciences

Volumn 21, Issue 4, 1996, Pages 348-352

  Wood Baker, R ^a,b   Lau, L ^a   Howarth, P H ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b Division of Clinical Sciences   (Australia)

Author keywords

Histamine receptor blockers; Histamine receptors; Nasal mucosa

Indexed keywords

CETIRIZINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NOSE; NOSE AIRFLOW; NOSE AIRWAY RESISTANCE; NOSE MUCUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULARIZATION;

EID: 0029784096     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2273.1996.tb01085.x     Document Type: Article

References (20)

1. MYGIND N. (1982) Mediators of nasal allergy. J. Allergy Clin. Immunol. 70, 149-159
2. NACLERIO R., MEIER H. & KAGEY-SOBOTKA A. (1983) Mediator release after nasal airway challenge with allergen. Am. Rev. Respir. Dis. 128, 597-602
3. GOMEZ E., CORRADO O., BALDWIN D., SWANSTON A. & DAVIES R. (1986) Direct in vivo evidence for mast cell degranulation during allergen-induced reactions in man J. Allergy Clin. Immunol. 78, 637-645
4. HOWARTH P. & HOLGATE S. (1984) Comparative trial of two non-sedative H1 antihistammes, terfenadine and astemizole, for hay fever. Thorax. 39, 668-672
5. BRADFORD M.(1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal. Biochem. 72, 248-254
6. WEEKE B. (1973) Rocket immunoelectrophoresis. Scand. J. Immunol. 1, 37-46
7. GENGO F., DRABRONZO J., YURCHAK A., LOVE S & MILLER J. (1987) The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine. Clin. Pharmacol. Ther. 42, 265-272
8. RICHARDS D. (1983) Pharmacodynamics and pharmacokinetics of cimetidine and ranitidine. J. Clin. Gastroenterol. 5, 81-90
9. 1-receptor antagonist therapy. Clin. Pharmacokinet. 21, 372-393
10. CORRADO O., GOULD C., KASSAB J. & DAVIES R. (1986) Nasal response of rhinitic and non-rhinitic subjects to histamine and methacholine: a comparative study. Thorax. 41, 863-868
11. RAJAKULASINGHAM K., POLOSA R., LAU L., CHURCH M., HOLGATE S. & HOWARTH P. (1994) Comparative nasal effects of bradykinin and histamine: influence on nasal airways resistance and plasma protein exudation. Thorax, s, 324-329
12. 2 receptors in the human nose: rationale for topical use of combined antihistamine preparations. J. Allergy Clin. Immunol. 70, 211
13. 2 histamine antagonists on alterations in nasal airflow resistance induced by topical histamine provocation. J. Allergy Clin. Immunol. 78, 856-860
14. 2 receptor subtypes. J Allergy Clin. Immunol. 93, 606-614
15. SHELTON D. & EISER N. (1994) Histamine receptors in the human nose. Clin. Otolarynyol. 19, 45-49
16. MEREDITH S., RAPHAEL G., BARANIUK J., BANKS S. & KALINER M. (1989) The pathophysiology of rhinitis (III). The control of IgG secretion. J. Allergy Clin. Immunol. 84, 920-930
17. SVENSSON C., BAUMGARTEN C., PIPKORN U., ALKNER U. & PERSSON C. (1989) Reversibility and reproducibility of histamine induced plasma leakage in nasal airways. Thorax. 44, 13-18
18. RAPHAEL G., MEREDITH S., BARANIUK J., DRUCE H., BANKS S. & KALINER M. (1989) The pathophysiology of rhinitis (II). Assessment of the sources of protein in histamine-induced nasal secretions. Am. Rev. Respir. Dis. 139, 791-800
19. BATEMAN D., CHAPMAN P. & RAWLINGS M. (1983) Effects of astemizole on histamine-induced weal and flare. Eur. J. Clin. Pharmac. 25, 547-551
20. ROBERTSON J. & GREAVES M. (1978) Responses of human skin blood vessels to synthetic histamine analogues. Br. J. Clin. Pharmacol. 5, 319-322